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Abstract 
Background: Energy metabolism disorder is a critical process in lung ischemia–reperfusion injury (LIRI). This study 
was aimed to determine the effects of resolvin D1 (RvD1) on the energy metabolism in LIRI.
Methods: Forty Sprague–Dawley rats were divided into the following groups: Sham group; untreated ischemia–rep-
erfusion (IR) control; IR treated with normal saline (IR-NS); and IR treated with RvD1 (IR-RV) (100 μg/kg, iv). LIRI and 
energy metabolism disorder were determined in these rats.
Results: The results revealed that the levels of interleukin (IL)-1β, tumor necrosis factor-α, IL-10, monocyte chemoat-
tractant protein-1, macrophage inflammatory protein-2, cytokine-induced neutrophil chemoattractant-1, injured 
alveoli rate, apoptosis index, pulmonary permeability index, malondialdehyde, ADP, and lactic acid were increased, 
whereas the levels of ATP, ATP/ADP, glycogen, Na+–K+-ATPase, superoxide dismutase, glutathione peroxidase activity, 
pulmonary surfactant associated protein-A, and oxygenation index were decreased in rats with LIRI. Except for IL-10, 
all these biomarkers of LIRI and its related energy metabolism disorder were significantly inhibited by RvD1 treatment. 
In addition, histological analysis via hematoxylin–eosin staining, and transmission electron microscopy confirmed that 
IR-induced structure damages of lung tissues were reduced by RvD1.
Conclusion: RvD1 improves the energy metabolism of LIRI disturbance, protects the mitochondrial structure and 
function, increases the ATP, glycogen content and Na+–K+-ATPase activity of lung tissue, balances the ratio of ATP/
ADP and finally decreases the rate of apoptosis, resulting in the protection of IR-induced lung injury. The improved 
energy metabolism after LIRI may be related to the reduced inflammatory response, the balance of the oxidative/anti-
oxidant and the pro-inflammatory/anti-inflammatory systems in rats.
Keywords: Resolvin, Lung ischemia/reperfusion injury, Inflammatory factor, Oxidative stress, Energy metabolism
© 2016 Zhao et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Lung ischemia–reperfusion injury (LIRI) occurs in many 
cases, such as the cardiopulmonary bypass, lung trans-
plantation and post enucleation of pulmonary embolism 
[1–3]. In addition, LIRI is also involved in other situa-
tions including shock, respiratory failure caused by lower 
limb and trunk ischemia–reperfusion (IR) and acute res-
piratory distress syndrome [4–6]. Recently, much atten-
tion has been paid to the pulmonary dysfunction resulted 
from LIRI. However, due to the complex of the mecha-
nism of LIRI and its involved factors, the effective meth-
ods for prevention and treatment of LIRI are still very 
limited. More recently, the energy metabolism disorder 
has been found to be the key process of ischemia–rep-
erfusion injury (IRI) [7]. Studies have demonstrated that 
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of metabolic disorders could remarkably reduce the 
organ IRI [8, 9]. Nevertheless, the energy metabolism of 
LIRI has its own characteristics, and there has been little 
research in this new area.
The endogenous lipid mediators, such as resolvin (Rv) 
and lipoxin, have been confirmed to have the anti-inflam-
matory effect in many studies [10, 11]. These specialized 
pro-resolving mediators have conserved structures with 
many functions in host defense, pain, organ protection 
and tissue remodeling [12]. In addition, these bioactive 
substances have been found to have a protective effect on 
organ ischemia reperfusion injury [13–19]. Recently, it 
has been reported that RvD1 could preserve the activity 
of Na+–K+-ATPase and relieve the lung injury induced 
by oxidative stress and inflammatory response [20, 21]; 
however, little research has been reported about the 
effect of RvD1 on the energy metabolism of LIRI.
In this study, we aim to investigate the protective effect 
and the related mechanisms of RvD1 on the lung energy 
metabolism caused by LIRI in rats, and hope to provide a 
new idea and its experimental evidence for the treatment 
of LIRI. In particularly, through the intravenous injec-
tion of RvD1, we studied the effects of RvD1 on the ATP, 
ADP, glycogen, lactic acid content, the activity of Na+–
K+-ATPase, the inflammatory response and the oxida-
tive stress in lung tissue. Meanwhile, the pathological 
changes, apoptosis rate and pulmonary function in the 
lung tissue were also evaluated.
Methods
Rat model of LIRI
The animal procedures were approved by Wenzhou Med-
ical University Animal Care and Use Committee, which 
were certified by the Chinese Association of Accredita-
tion of Laboratory Animal Care and were consistent with 
the Guide for the Care and Use of Laboratory Animals 
[updated (2011) version of the NIH guidelines]. Male 
Sprague–Dawley (SD) rats (8 weeks old) were fed a stand-
ard diet and maintained in the controlled environment of 
the animal center at 25 ±  1  °C under a 12 h light–dark 
cycle. The LIRI rat model was induced by the following 
procedures. Briefly, rats were anesthetized by an intra-
peritoneal injection of 10  % chloral hydrate (300  mg/kg 
body weight) and placed in a supine position. The ani-
mals were then intubated for artificial ventilation with 
oxygen using a small animal breathing machine (tidal vol-
ume 5 ml, frequency 70 per min) and electrocardiograph 
monitor. Thoracotomy was performed at the anterior lat-
eral side of the left fourth intercostal. The muscular layer 
and pleura were gentle dissected to expose the heart and 
lung. After that, the hilum of left lung was dissociated 
and the artery clamp was used to pass through the hilum 
of lung from the upper right to lower left. The whole 
clamped left hilum was clearly exposed by slightly stirring 
up the clamp. Before blocking, heparin was injected by 
i.v. (1 mg/kg body weight). After ischemia for 45 min, the 
artery clamp was removed (no blocking in sham group) 
and then reperfusion was started and lasted for 150 min. 
During the reperfusion time, 0.5  ml normal saline (NS) 
was injected by i.v. every hour to maintain the body fluid. 
Finally, after the chest wall was closed and the body tem-
perature was maintained using a 37 °C warming plate.
Animal grouping and treatments
Resolvin D1 (RvD1, C22H32O5, 7S,8R,17S-trihydroxy-
4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid, please 
see Additional file  1: Figure S1 in the Supplementary 
Material) was purchased from Cayman Chemical Com-
pany (Ann Arbor, USA). Forty SD rats were randomly 
divided into four groups (10 rats/group) as follows: 
(1) Sham group: no blocking of hilum of left lung after 
thoracotomy; (2) untreated IR control (IR-C) group: 
blocking of hilum of left lung after thoracotomy for 
45  min, followed by reperfusion for 150  min; (3) IR 
treated with normal saline (IR-NS) group: after blocking 
the hilum of left lung for 45 min, reperfusion for 10 min 
then injection 2 ml/kg NS by formal vein, and the total 
reperfusion time was 150 min; (4) IR treated with RvD1 
(IR-RV) group: after blocking the hilum of left lung for 
45 min, reperfusion for 10 min then injection 100 μg/kg 
RvD1 by formal vein and the total reperfusion time was 
150 min.
Blood and tissue harvest
Blood samples were collected in each group immediately 
before thoracotomy (T1) and after the experiments (T2). 
In Sham group, T2 was achieved after 195  min of the 
artery clip across the left hilus pulmonis. For all the other 
groups, T2 blood samples were obtained after 150  min 
of reperfusion. Rats were killed after blood collection. 
The bronchoalveolar lavage fluid (BALF) was then col-
lected by washing the airways of the left lungs three times 
with a total of 5  mL of phosphate buffer solution (PBS) 
through a tracheal cannula (recovery rate >80 %), which 
was pooled and centrifuged at 3000 rpm/min for 15 min 
for further use. At time point of T2, the left lung tissue of 
rats was dissected to measure the W/D value (wet to dry 
weight ratio, W/D). Other lung tissue were fixed in 4 % 
paraformaldehyde or frozen in −70  °C refrigerator for 
further analysis.
Lung tissue hematoxylin–eosin (HE) staining 
and transmission electron microscopy (TEM)
The obtained lung tissue samples at T2 were fixed in 10 % 
neutral-buffered formalin and subsequently embedded 
in paraffin. Tissue sections (5  μm thick) were stained 
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with HE using a standard protocol and analyzed by light 
microscopy.
For TEM examination, lung tissue containing a 2 mm 
portion from the edge of the incision were immediately 
fixed in 0.1  M phosphate buffer containing 2.5  % glu-
taraldehyde and 2  % paraformaldehyde for at least 4  h. 
Samples were made of resin-embedded blocks, which 
were cut into 60 ~ 80 nm ultrathin sections with an ultra-
microtome (PT-XL, RMC, USA). The ultrathin sections 
were placed on carbon coated nickel grids and exam-
ined with an H-7500 transmission electron microscope 
(H-7500, Tokyo, Japan) operating at 80 kV.
Measurement of injured alveoli rate (IAR)
The IAR, a quantitative evaluation index of lung injury, 
were obtained in this study. The lung tissue sections 
stained with HE were observed under the light micro-
scope at 200× visual field. Total 200 alveoli were counted 
and those containing more than two red blood cells and 
white blood cells would be considered as the injured 
ones. Finally, the IAR was obtained [22].
Measurement of pulmonary surfactant associated 
protein‑A (SP‑A)
The lung tissue homogenate was centrifuged and the 
supernatant was used to determine the concentration 
of SP-A by a rat ELISA kit (R&D, USA) according to the 
manufacturer instructions.
Oxygenation index
The arterial blood gas analysis was performed at time 
point T2 and the ratio of PaO2 to FiO2 were then obtained 
and expressed as oxygenation index (oxygenation 
index = PaO2/FiO2).
Lung tissue W/D
The lung tissue W/D is an indicator of the lung tis-
sue edema. About 1 g of lung tissue were measured and 
named as wet weight. The tissue was then kept in 70 °C 
electrothermal constant-temperature dry box for 48  h 
and the weight of tissue was designed as dry weight. 
Finally, W/D was calculated and analyzed.
Pulmonary permeability index (PPI)
Samples of BALF precipitate were centrifuged and the 
supernate of BALF and blood serum was harvested for 
total protein analysis using the Bradford method. The 
ratio of total protein in BALF to the total protein in blood 
serum was calculated and named as PPI.
Measurement of Na+–K+‑ATPase activity in the lung tissue
The Na+–K+-ATPase activity was determined by meas-
uring the release of inorganic phosphate (Pi) from ATP 
according to the kit protocol (Jiancheng Bioengineering 
Institute, Nanjing, China). The amount of Pi was meas-
ured with the malachite green dye method.
Measurement of glycogen and lactic acid content  
in the lung tissue
The lung tissue homogenate was centrifuged and the 
supernatant was used to determine the concentration of 
glycogen by a rat ELISA kit (R&D, USA) according to the 
manufacturer instructions. The lactic acid content was 
also measured according to the manufacturer instruc-
tions (Jiancheng Bioengineering Institute, Nanjing, 
China).
The ATP, ADP contents and the ratio of ATP to ADP in the 
lung tissue
The ATP, ADP contents in the lung tissue were detected 
by the high performance liquid chromatography (HPLC). 
The ratio of ATP to ADP was then calculated based on 
the HPLC results.
Cytokine levels
For cytokine immunoassay, blood samples were collected 
by femoral venipuncture at time points T1 and T2. The 
serum levels of interleukin (IL)-1β, tumor necrosis factor 
(TNF)-α and IL-10 were measured using a rat ELISA kit 
(Boyun Biotech, Shanghai, China) in accordance with the 
kit instructions.
Chemokine levels
The lung tissue homogenate was centrifuged and the 
supernatant was used to determine the concentrations 
of Monocyte chemoattractant protein (MCP)-1, mac-
rophage inflammatory protein (MIP)-2, and cytokine-
induced neutrophil chemoattractant (CINC)-1 by a rat 
ELISA kit (R&D, Minneapolis, MN, USA) according to 
the manufacturer instructions.
Glutathione peroxidase (GSH‑PX), superoxide dismutase 
(SOD) activity and malondialdehyde (MDA) content 
determination
The lung tissue GSH-PX and SOD activity was deter-
mined on frozen tissue using Xanthine Oxidase assay kits 
(Jiancheng Bioengineering Institute, Nanjing, China). 
The MDA content was determined on frozen lung tissue 
by use of the thiobarbituric acid assay kit (Jiancheng Bio-
engineering Institute, Nanjing, China).
TdT‑mediated dUTP nick end labeling (TUNEL) assay
TUNEL assay was performed to determine the apopto-
sis of the lung tissue with TUNEL test kit (Roche, USA) 
according to manufacturer’s instructions. Five fields 
of view were automatically selected by the Image-Pro 
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Plus version 5.1 image analysis software. The percent-
age of apoptosis-positive cells was calculated for each 
field of view. The mean was calculated to obtain the per-
centage of apoptotic cells, and expressed as apoptotic 
index (AI). AI  =  (apoptotic nuclei count/total nucleus 
count) × 100 %.
Statistics
All data are presented as mean ±  standard error. One-
way ANOVA and two-tailed unpaired-samples T tests 
were used for statistical evaluation of the data. SPSS 17.0 
was used for data analysis. A P  <  0.05 was considered 
significant.
Results
Pathologic and ultrastructure changes of lung tissues
The pathological changes of lung tissue determined by 
HE staining in each group were shown in Fig. 1a. In sham 
group, the pulmonary alveoli and interstitium were intact 
with smooth thin alveolar wall and uniform alveolar sep-
tal thickness. No abnormality such as the apomorphosis, 
exudation and neutrophil infiltration was observed. In 
IR-C group and IR-NS group, damaged alveoli structure, 
dilated and congestive capillaries were seen. The thick-
ened interstitium was infiltrated with inflammatory cells, 
while the alveolar lumen was also filled with exudates, 
red blood cells and neutrophils. The histological condi-
tion in IR-RV group was much better than that in IR-NS 
and IR-C group. Less neutrophil infiltration and only 
slight dilatation of the capillaries were observed in the 
IR-RV group.
The ultrastructure of lung tissue was observed by 
TEM and exhibited in Fig.  1b. In sham group, the lung 
tissue ultrastructure was normal with tightly connected 
pulmonary capillary endothelial cells, intact basement 
membrane and integral type I and type II alveolar epi-
thelial cells. The mitochondrial cristae, microvilli and the 
lamellar body were clear. However, the ultrastructure was 
changed in IR-C and IR-NS groups. Their ultrastructure 
of lung tissue appeared serious abnormalities with swell-
ing pulmonary capillary endothelial cells, mitochon-
dria and shrinking nuclear membrane. Less pinocytosis 
vesicles could be seen in type I alveolar epithelial cells. 
Meanwhile, decreased numbers of microvilli and scarce 
lamellar bodies of the type II alveolar epithelial cells were 
observed, and a large number of inflammatory cells infil-
trated the alveolar septum and capillaries were identified. 
In IR-RV group, reduced injuries were found compared 
to IR-C and IR-NS groups. Their pulmonary capillary 
endothelial cells and mitochondria exhibited slight swell-
ing. More pinocytosis vesicles were seen in type I alveolar 
epithelial cells; and type II alveolar epithelial cell surface 
appeared an increasing number of microvilli and lamellar 
bodies. The alveolar septum showed edema and was still 
more than normal thickness but had no obvious inflam-
matory cell infiltration.
Fig. 1 Pathologic changes of lung tissues examined by HE staining 
and TEM. Lung tissues were dissected and performed with HE stain-
ing and TEM analysis. a HE staining of the lung tissue sections in the 
four groups; b TEM results of the tissue sections in the four groups. 
The HE staining results demonstrated no abnormal changes in the 
sham group; however, pathological changes happened severely in 
the IR-C and IR-NS group. The histological damages in IR-RV group 
were reduced compared with the other two IR groups. The TEM 
results demonstrated the lung tissue ultrastructure was normal with 
tightly connected pulmonary capillary endothelial cells, intact base-
ment membrane and integral type I and type II alveolar epithelial 
cells in sham group. Meanwhile, the mitochondrial cristae, microvilli 
and the lamellar body were clear. However, the ultrastructure was 
changed in IR-C and IR-NS groups. Their ultrastructure of lung tissue 
appeared serious abnormalities. In IR-RV group, reduced injuries were 
found compared to the other two IR groups
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The influence of RvD1 on lung injury and lung function 
caused by LIRI
The pathological changes of the four groups and the IAR 
results were demonstrated in Fig. 2a, b. The sham group 
showed no abnormal change; however, the lung tissue 
in IR-C and IR-NS group exhibited the damaged alveoli 
and inflammatory cells infiltration and other structure 
changes. In the group of RvD1 treatment, the tissue dam-
ages were reduced. For the IAR, all the three IR groups 
exhibited higher values than the sham group, which 
corresponded to the HE staining results (F  =  297.43; 
P < 0.001). No difference of the IAR was found between 
the IR-C and IR-NS groups; however, compared to the 
IR-C group, the IAR in IR-RV was significantly higher 
(F =  162.62; IR-NS vs IR-C, P =  0.390; IR-RV vs IR-C, 
P < 0.001).
The results of SP-A, oxygenation index, lung tissue 
W/D and PPI were shown in Fig. 2c–f. The highest val-
ues of SP-A and oxygenation index were found in the 
sham group (F = 70.08; P < 0.01 and F = 48.40; P < 0.001 
for SP-A and oxygenation index, respectively). After IR 
injury, both of them were decreased. Interestingly, the 
use of RvD1 brought the values back, which resulted in 
the statistic higher level in the IR-RV group when com-
pared with the IR-C group (F =  65.68 for SP-A; IR-NS 
vs IR-C, P = 0.881; IR-RV vs IR-C, P < 0.001. F = 15.32 
for oxygenation index; IR-NS vs IR-C, P = 0.152; IR-RV 
vs IR-C, P  <  0.001). The W/D and PPI were increased 
in the IR groups when compared with the sham group 
(F = 87.81 and F = 505.43 for W/D and PPI, respectively; 
both P  <  0.001); however, the IR-RV group showed sig-
nificantly lower values of W/D and PPI compared with 
these in the IR-C group (F =  24.79 for W/D; IR-NS vs 
IR-C, P = 0.973; IR-RV vs IR-C, P < 0.001. F = 358.23 for 
PPI; IR-NS vs IR-C, P = 0.702; IR-RV vs IR-C, P < 0.001).
The effects of RvD1 on IR‑induced energy metabolism 
in lung tissues
The results of Na+–K+-ATPase activity, glycogen and lac-
tic acid levels in the lung tissues were shown in Fig. 3a–
c. Compared to the sham group, the Na+–K+-ATPase 
activity and glycogen levels were remarkably decreased 
(F  =  106.97 and F  =  42.70 for Na+–K+-ATPase and 
glycogen, respectively; both P  <  0.001). However, in the 
IR-RV group, the situation was better than the IR-C and 
IR-NS group, which showed significantly higher levels 
than the IR-C group (F  =  47.26 for Na+–K+-ATPase; 
IR-NS vs IR-C, P  =  0.584; IR-RV vs IR-C, P  <  0.001. 
F = 13.49 for glycogen; IR-NS vs IR-C, P = 0.568; IR-RV 
vs IR-C, P < 0.001). The lactic acid level showed the oppo-
site trend, which was increased in all the three IR groups 
(F = 271.65; all P < 0.01) but the lactic acid level in IR-RV 
was evidently lower than the IR-C group (F  =  204.16; 
IR-NS vs IR-C, P = 0.069; IR-RV vs IR-C, P < 0.001).
The ATP, ADP and ATP/ADP in lung tissues were 
shown in Fig.  3d–f. At T2, when compared to sham 
group, the ATP and ATP/ADP levels were significantly 
decreased in IR-C and IR-NS group but with higher level 
of ADP (F = 95.48 and F = 38.78 and F = 61.85 for ATP, 
ADP and ATP/ADP, respectively; all P < 0.01). In IR-RV 
group, the ATP and ADP showed lower levels than the 
sham group (F = 95.48 for ATP; P < 0.001. F = 38.78 for 
ADP; P = 0.04). Compared to IR-C group, the ATP and 
ATP/ADP levels in IR-RV group were significantly higher 
but with lower ADP level (F = 28.83 for ATP; IR-NS vs 
IR-C, P = 0.928; IR-RV vs IR-C, P = 0.001. F = 35.73 for 
ADP; IR-NS vs IR-C, P = 0.998; IR-RV vs IR-C, P < 0.001. 
F = 45.88 for ATP/ADP; IR-NS vs IR-C, P = 0.895; IR-RV 
vs IR-C, P < 0.001). No changes were found in the levels 
of ATP, ADP and ATP/ADP between the IR-C and IR-NS 
group.
The effects of RvD1 on inflammatory and oxidative stress 
reaction after LIRI
The serum levels of IL-1β, TNF-α and IL-10 in the four 
groups were described in Fig.  4a–c. At T1, no differ-
ence was found among the four groups. At T2, the lev-
els of IL-1β and TNF-α in IR-C and IR-NS group were 
higher than the sham group (F  =  18.03 and F  =  24.91 
for IL-1β, TNF-α, respectively; both P  <  0.001). How-
ever, there was no difference between the IR-RV and 
sham group (F = 18.03 for IL-1β; P = 0.316. F = 24.91 for 
TNF-α; P = 0.196). For the IL-10, all the three IR groups 
had higher levels than the sham group (F  =  21.95; all 
P < 0.001). Compared to the IR-C group, the IL-1β and 
TNF-α levels in IR-RV group were significantly decreased 
but with increased level of IL-10 (F  =  26.31 for IL-1β; 
IR-NS vs IR-C, P  =  0.912; IR-RV vs IR-C, P  <  0.001. 
F =  25.57 for TNF-α; IR-NS vs IR-C, P =  0.900; IR-RV 
vs IR-C, P  <  0.001. F  =  3.41 for IL-10; IR-NS vs IR-C, 
P = 0.776; IR-RV vs IR-C, P = 0.045). However, the three 
parameters showed no difference between the IR-NS and 
IR-C group.
The MCP-1, MIP-2, and CINC-1 content in lung tis-
sues in each group were listed in Fig. 4d–f. At the time 
point T2, MCP-1, MIP-2 and CINC-1, levels in all the 
IR groups were higher than the sham group (F = 35.68, 
F  =  33.13 and F  =  45.51 for MCP-1, MIP-2, CINC-1, 
respectively; all P < 0.01). Compared to IR-C group, the 
levels of MCP-1, MIP-2 and CINC-1 decreased in IR-RV 
group (F  =  14.28 for MCP-1; IR-NS vs IR-C, P  =  1.0; 
IR-RV vs IR-C, P  <  0.001. F  =  8.58 for MIP-2; IR-NS 
vs IR-C, P = 0.99; IR-RV vs IR-C, P = 0.002. F = 15.32 
for CINC-1; IR-NS vs IR-C, P  =  0.359; IR-RV vs IR-C, 
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P < 0.001). However, no changes were found between the 
IR-C and IR-NS group.
The GSH-PX, SOD activity and MDA content of the 
lung tissue in the four groups were shown in Fig.  4g–i. 
We could see that the GSH-PX and SOD activity in IR-C 
and IR-NS were significantly lower than the sham group 
(F = 52.51 and F = 103.11 for GSH-PX and SOD, respec-
tively; both P < 0.001). No difference was found between 
the IR-RV and sham group; however, IR-RV group 
showed remarkably higher activity than the IR-C group 
(F = 51.81 for GSH-PX; IR-NS vs IR-C, P = 0.503; IR-RV 
vs IR-C, P  <  0.001. F =  89.17 for SOD; IR-NS vs IR-C, 
P =  0.995; IR-RV vs IR-C, P  <  0.001). As for the MDA 
production, all the IR groups showed higher value than 
the sham group (F  =  120.34; IR-C vs sham and IR-NS 
vs sham, both P  <  0.001; IR-RV vs sham, P  =  0.049). 
Fig. 2 The influence of RvD1 on lung injury and lung function. At time point T2, lung tissue, BALF and arterial blood were collected immediately 
after IR procedure was completed. H&E staining of lung tissues, IAR, SP-A, W/D, oxygenation index and PPI were measured as described in “Methods” 
section. a HE staining; b IAR; c SP-A; d oxygenation index; e W/D; f PPI. Data were analyzed by one-way ANOVA and unpaired-samples T test. n = 10 
for each group *P < 0.05 for comparisons of IR-C, IR-NS and IR-RV groups with Sham group; #P < 0.05 for comparisons of IR-NS and IR-RV groups 
with IR-C group
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However, after the using of RvD1, MDA production was 
significantly reduced in IR-RV group (F =  81.51; IR-NS 
vs IR-C, P = 0.170; IR-RV vs IR-C, P < 0.001).
Effect of RvD1 on LIRI‑induced cell apoptosis
The effect of RvD1 on lung tissue cell apoptosis at T2 
was shown in Fig.  5a. Cells with apoptotic morphologi-
cal features and with tan or brown nuclei were judged to 
be apoptotic cells. In Fig. 5a, only several apoptotic cells 
existed in the sham group, however, the number of apop-
totic cells increased significantly in the IR-C and IR-NS 
group. Interestingly, after the treatment with RvD1, the 
apoptotic cells were decreased in the IR-RV group.
In terms of the AI (Fig. 5b), the three IR groups showed 
much higher values than the sham group (F = 77.05; all 
P  <  0.001). No difference was found between the IR-C 
and IR-NS group. However, compared to the IR-C group, 
the AI in IR-RV was significantly reduced (F  =  31.08; 
IR-NS vs IR-C, P = 0.647; IR-RV vs IR-C, P < 0.001).
Discussion
LIRI is a pathological phenomenon, which refers to the 
rapid exacerbation of lung injury when lung tissue suf-
fers from ischemia for a period and then blood supply is 
restored. Since LIRI happens more and more frequently 
in clinical practice in recent years, it is necessary to 
investigate its related mechanisms and the preventive 
or treatment methods [1, 23, 24]. Yet, the pathogenesis 
of the LIRI has not been fully clarified. Although many 
drugs were reported that they can reduce the LIRI in 
animal experiments, it is still very difficult to apply them 
into clinic due to their unsatisfactory effects or side 
effects [25–28]. Therefore, finding the safe and effective 
medications will provide great medical applications for 
the treatment of LIRI. The research about the mecha-
nisms of LIRI has been focused on the following aspects: 
oxygen radicals, lipid peroxidation and excessive inflam-
matory response caused by neutrophil infiltration and 
inflammatory mediators [29]; however, there is very little 
research to study the energy metabolism disorder and its 
prevention, which was considered to be one of the causes 
of the LIRI and an important link in the pathogenesis of 
many other diseases [8, 30, 31].
Since the discovery of lipoxins, Rv has become a new 
lipid molecule that can reduce the inflammation and 
protect the tissue structure by restraining the prolifera-
tion of neutrophils, macrophages and other inflamma-
tory cells [32–35]. The research about the protective 
effect of Rv on the IRI organs has just started and only 
few reports about the heart, brain and intestines can be 
found [14, 15, 36]. However, the effects of RvD1 on LIRI 
are still unknown.
Fig. 3 The effects of RvD1 on IR-induced energy metabolism in lung tissues. At T2, lung tissue was collected immediately after the IR procedure was 
completed and kept frozen in liquid nitrogen. Na+–K+-ATPase activity, glycogen, lactic acid, and ATP, ADP were measured as described in “Methods” 
section. a Na+–K+-ATPase; b glycogen; c lactic acid; d ATP; e ADP; f ATP/ADP. Data were analyzed by one-way ANOVA and unpaired-samples T test. 
n = 10 for each group *P < 0.05 for comparisons of IR-C, IR-NS and IR-RV groups with Sham group; #P < 0.05 for comparisons of IR-NS and IR-RV 
groups with IR-C group
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The pathological changes of the lung tissue in the rat 
model of LIRI, especially the ultra-structural changes, 
can reflect the degree of lung injury in a more subtle way. 
Through TEM observation, we found that severe dam-
age on the capillary alveolar respiratory membrane was 
caused by LIRI and other pathological changes such as 
the swollen type I epithelial cells, disappeared lamel-
lar body, swollen mitochondria and dilated endoplas-
mic reticulum. HE staining showed the damaged alveoli, 
angiotelectasis, thickened alveolar septal infiltrated with 
inflammatory cells and the increased IAR level. With 
other data including the abnormality of W/D and PPI 
which reflected pulmonary edema and permeability as 
well as the AI in the three IR group, we confirmed that 
LIRI can cause severe lung injury. Fehrenbach et al. [37] 
thought the declining levels of SP-A after lung trans-
plantation could indicate the progression of IRI. The 
preservation-dependent improvement of alveolar sur-
factant integrity after IR was associated with alterations 
in intra-alveolar SP-A levels. In lung transplantation 
experiments, the level of SP-A, SP-B and SP-C, markers 
of lung injury, in transplanted lungs treated with nitric 
oxide (NO) was decreased. Valiño et  al. [38] concluded 
that the treatment with inhaled NO is deleterious for 
the surfactant system and causes a parallel worsening of 
arterial oxygenation. Therefore, SP-A level can be one of 
the indicators to LIRI. In this study, when the rats suf-
fered from LIRI, the SP-A level and oxygenation index 
were significantly decreased, indicating the damage of 
the lung function. Interesting, we found that RvD1 could 
reduce cellular apoptosis in lung tissues, which is con-
sistent with previous reports [39, 40]. The direct effects 
of RvD1 on the apoptosis of isolated lung cells should be 
tested in future studies. With the use of the RvD1, the AI 
Fig. 4 The effects of RvD1 on inflammatory and oxidative stress reaction. At T1, blood was collected immediately before thoracotomy. At T2, blood 
was collected after IR procedure was finished. At T2, lung tissue was collected immediately after the IR procedure was completed and kept frozen in 
liquid nitrogen. Inflammatory factors and GSH-PX, SOD, MDA were measured as described in “Methods” section. a IL-1β; b TNF-α; c IL-10; d MCP-1; e 
MIP-2; f CINC-1; g GSH-PX; h SOD; i MDA. Data were analyzed by one-way ANOVA and unpaired-samples T test. n = 10 for each group *P < 0.05 for 
comparisons of IR-C, IR-NS and IR-RV groups with Sham group; #P < 0.05 for comparisons of IR-NS and IR-RV groups with IR-C group
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was reduced significantly in IR-RV group, and the dam-
age on the lung tissue was relieved with less pathological 
changes of the lung, less infiltrated inflammatory cells, 
lower W/D and PPI, and higher levels of SP-A and oxy-
genation index, suggesting the protective effect of RvD1 
on the lung tissue when suffering from LIRI.
Some researchers believed that the energy metabolism 
disorder was the initiation of IRI [7]. Energy metabolism 
disorder, especially the deficiency of high energy phos-
phate compounds and carbohydrate is considered to 
be one of the main reasons of IRI [31, 41]. Extracorpor-
eal circulation can cause damage to the internal organs, 
such as brain, kidney, lung, and liver. Dhein et  al. [42] 
revealed that extracorporeal circulation decreased the 
ATP content in kidney and liver, but minocycline could 
significantly increase the ATP level in organs and reduce 
the injuries of kidney and liver. The Na+–K+-ATPase, a 
kind of protease, is located in the membranes of the cells 
and organelles functioning in substance transport, energy 
conversion, information transmission, cell membrane 
integrity maintenance and tissue metabolism. It can be 
a reliable index of the metabolic disturbance and tissue 
damage. Belliard [43] found that the Na+–K+-ATPase 
level on the cell membrane played a vital role in cell 
survival when studying the sodium pump and cell sur-
vival condition through an ischemia reperfusion model. 
The continuous intermittent low pressure hypoxia can 
relieve the reperfusion injury by enhancing the activ-
ity of Na+–K+-ATPase in guinea pig myocardium [44]. 
Due to the lack of substance, the energy synthesis by 
the mitochondria encountered obstacle, resulting in the 
decreased activity of the energy dependent Na+–K+-
ATPase and finally a series of pathological response to 
the injury. Some degree of functional coupling of glyco-
lytic ATP and Na+–K+-ATPase activity exists [45]. The 
decreased level of ATP and increased consumption of 
ATP should limit the Na+–K+-ATPase activity and acti-
vate the exchange of Na+–Ca2+, resulting in the overload 
of Ca2+. Moreover, the decrease of ATP content can also 
affect the activity of the calcium pump on cell membrane 
and in the cytoplasm, aggravating the overload situation 
of Ca2+. The increase of intracellular calcium increased 
the consumption of ATP; at the same time, Ca2+ overload 
can cause the accumulation of Ca2+ in the mitochondria, 
affecting the coupling of the electron transfer during the 
process of oxidative acidification and further aggravating 
the energy metabolic disturbance [46]. When suffered 
from IRI, Na+–K+-ATPase activity was inhibited, which 
would cause the cell toxicity, mitochondria and lysosomal 
membrane rupture, and finally increase inflammatory 
reaction and tissue damage [47]. On the other hand, Ca2+ 
overloading can increase the activity of many enzymes, 
and destroy the cell membrane, increasing the generation 
of free radicals and more damage to the lung tissue [48].
The results of this experiment showed that the 
decreased ATP level, the increased ADP level as well 
as the decreased ATP/ADP of the lung tissue appeared 
when rats suffered from LIRI. The content of ATP can not 
only reflect the process of oxidative respiratory chain of 
mitochondria and the ability of synthesizing high energy 
phosphates, but also the energy storage of the cells. The 
ratio of ATP to ADP (ATP/ADP) is a main factor that 
Fig. 5 Inhibitory effect of RvD1 on LIRI-induced cell apoptosis. At T2, Apoptosis was determined by TUNEL assay according to manufacturer’s 
instructions. Cells with apoptotic morphological features and with tan or brown nuclei were judged to be apoptotic cells. a TUNEL assay, group 
Sham: a small amount of apoptotic cells in lung tissue; group IR-C and group IR-NS: apoptotic cells in lung tissue increased significantly; group 
IR-RV: apoptotic cells were between group Sham and group IR-C. b AI (apoptotic nuclei count/total nucleus count) was represent with histogram. 
Data were analyzed by one-way ANOVA and unpaired-samples T test. n = 10 for each group *P < 0.05 for comparisons of IR-C, IR-NS and IR-RV 
groups with Sham group; #P < 0.05 for comparisons of IR-NS and IR-RV groups with IR-C group
Page 10 of 13Zhao et al. J Transl Med  (2016) 14:81 
affects the oxidative phosphorylation. Decreased ratio 
refers to the weakened oxidative phosphorylation func-
tion and less ATP synthesis, which explained the increase 
of ADP content that was expected to be the result of the 
disturbance of synthesis of ATP. In addition, lower levels 
of glycogen and Na+–K+-ATPase activity as well as the 
higher lactic acid content caused by the acidism and gly-
colysis in the lung tissue confirmed that LIRI would cause 
evident energy metabolic disturbance. RvD1 can protect 
the structure and function of mitochondria and can fur-
ther maintain the function of oxidative phosphorylation, 
promote ATP synthesis and delay the depletion of ATP, 
and finally recover the ratio of ATP to ADP. Meanwhile, 
it can enhance the activity of Na+–K+-ATPase to bal-
ance the homeostasis of the cells. Additionally, through 
up-regulating the glycogen content and down-regulating 
the lactic acid level, the energy metabolism was improved 
remarkably by RvD1, resulting in the less damage of the 
lung tissue when experiencing LIRI. Sukoyan et  al. [49] 
agreed that the LIRI can be alleviated through improv-
ing cellular energy metabolism, such as protecting the 
mitochondrial oxidative respiratory activity, enhanc-
ing the ability of mitochondrial oxidative phosphoryla-
tion function and generation of high-energy phosphate 
compounds, as well as making the cells utilize the high-
energy phosphate compounds. Ying et  al. [50] thought 
that mitochondrial dysfunction was an important cause 
of IRI and the key factor to initiate apoptosis. This experi-
ment is also observed RvD1 can reduce IR-induced apop-
tosis by improving energy metabolism and mitochondrial 
function,
There is still no clear evidence on whether RvD1 func-
tions in the part of the energy metabolism, in a direct or 
indirect way. The relationship among the energy meta-
bolic disturbance, inflammatory response and the oxi-
dative stress response should be mutual connected and 
influenced as well as reciprocal causation. LIRI, charac-
terized by inflammatory reaction and oxidative stress, 
can destroy the balance of the oxidative/anti-oxidative 
and pro-/anti-inflammatory systems. Many studies con-
firmed that the secretion of the inflammatory cytokines 
TNF-α, MIP-2, MIP-1, MCP-1 and CINC-1 would be 
increased during LIRI, which benefited the recruiting of 
neutrophils and further promote lung injury [51, 52]. In 
our study, we got the similar results. In particular, LIRI 
led to the large increase of the serum levels of IL-1, TNF-
α, IL-10 and the concentrations of MCP-1, MIP-2 and 
CINC-1 in the lung tissue. In addition, more numbers of 
neutrophils and aggressive lung damage were observed in 
the lung tissue. Inflammation is associated with an oxi-
dative stress reaction, which is produced in the develop-
ment of inflammation, that which has positive feedback 
on inflammation itself [53]. Oxidative stress is considered 
to be an important pathogenic event in IRI. The delete-
rious effects of LIRI are in part mediated by the forma-
tion of free radicals and super oxides [54]. When the 
body suffered from ischemia, the function of the oxygen 
free radical scavenging system would be reduced or even 
totally loss; however, the activity of oxygen free radical 
generation system in the other way is enhanced. Once the 
blood supply is recovered, the oxygen free radicals would 
accumulate rapidly and further cause the damage of the 
tissue [55]. The scavenging of the free radicals is mainly 
achieved by a series of antioxidant enzymes, such as SOD 
and GSH-PX. Our experimental results showed that LIRI 
cause the imbalance between the production and elimi-
nation of the free radical, the increase of the MDA con-
tent, and the reduced activity of the SOD and GSH-PX 
[56, 57]. All the above results suggested that oxidative 
stress happened and the scavenging ability of free radicals 
was reduced, leading to the lung injury. At the same time, 
the increase number of white blood cell infiltration in the 
lung tissue can also produce a variety of free radicals and 
activate the lipid peroxidation of the cell membrane and 
damage the important components of the cells. Mito-
chondrial dysfunction and ATP level in the lung tissue 
are associated with various forms of lung injury and dis-
ease [58]. Study showed that due to the production of a 
large amount of free radicals, mitochondria experienced 
stress reaction, resulting in the decreased mitochondrial 
function, cellular energy metabolism disturbance, the 
reduced intracellular ATP, and low activity of Na+–K+-
ATPase [59, 60]. In the present study, we found that LIRI 
could produce many kinds of toxic mediators, including 
oxygen free radicals, TNF, IL, and chemokines, which 
could recruit the neutrophil cells and other inflammatory 
cells, destroy the mitochondria structure and decrease 
the ATP level and the activity of the Na+–K+-ATPase, 
leading to the disturbance of the energy metabolism 
and further aggravate the tissue damage. RvD1 is able 
to restrain the infiltration of the inflammatory cells and 
the secretion of IL-1, TNF-α, MCP-1, MIP-2, and CINC, 
up-regulate the IL-10 level, enhance the SOD and GSH-
PX activity and reduce the MDA content to restore the 
balance of the oxidant/antioxidant and pro-/anti-inflam-
matory system, and protect mitochondria. Therefore, the 
energy metabolism can be improved, leading to the less 
damage of the lung tissue.
RvD1 mainly functions in the inflammatory process, 
but it would not participate in the maintenance of the 
physiological functions. Therefore, this new type of 
anti-inflammatory drug will not interfere with the nor-
mal physiological activity and should cause no obvi-
ous adverse reaction in  vivo. It is thus different from 
other anti-inflammatory agents, such as the glucocor-
ticoid, the non steroidal anti-inflammatory drugs or the 
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immune-suppressor, which usually induce a variety of 
adverse reactions. However, the unstable property, short 
half-life and the high price, the unknown dosage and 
the administrating timing, the uncertain frequency and 
delivery ways might limit its application. Therefore, the 
development of stable analogue could help to achieve the 
purpose of clinical application. In addition, the reported 
models and our animal models of LIRI were achieved by 
blocking and then loosing the pulmonary hilus, which 
not only blocked the pulmonary artery but also the bron-
chus and bronchial artery, leading to the difference from 
the clinical LIRI. The lung tissue has a dual blood sup-
ply system (pulmonary artery and bronchial artery) and 
these two systems anastomose extensively. Besides, the 
lung tissue can directly obtain oxygen by pulmonary 
ventilation, which makes the LIRI different from other 
organ’s IRI [61]. As a result, there may be some difference 
between this animal model of LIRI and the clinical situ-
ation. Much effort is still needed to improve the animal 
model of LIRI and make it closer to the clinical practice.
Conclusions
In conclusion, RvD1 is able to improve the energy metab-
olism after LIRI, protect the mitochondrial structure and 
function from damage, increase the lung tissue ATP and 
glycogen content, recover the ATP/ADP ratio, enhance 
the Na+–K+-ATPase activity and decrease the lactic acid 
content. All the above effects may combine together, 
reduce the apoptosis in the lung tissue and protect the 
rats from LIRI. RvD1 can restore the balance of the oxi-
dant/antioxidant and pro-/anti-inflammatory system. 
Therefore, the energy metabolism can be improved, lead-
ing to the less damage of the lung structure and function.
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